80 FR 38712 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 129 (July 7, 2015)

Page Range		38712-38712
FR Document		2015-16527

Federal Register, Volume 80 Issue 129 (Tuesday, July 7, 2015)

[Federal Register Volume 80, Number 129 (Tuesday, July 7, 2015)]
[Notices]
[Page 38712]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-16527]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Seek, Test, Treat and Retain For Youth and Young 
Adults Living with or at High Risk for Acquiring HIV (R01).
    Date: July 9, 2015.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Churchill Hotel, 1914 Connecticut Avenue NW., Washington, 
DC 20009.
    Contact Person: Nadine Rogers, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, Bethesda, MD 20892-
9550, 301-402-2105, [email protected].
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 30, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-16527 Filed 7-6-15; 8:45 am]
BILLING CODE 4140-01-P

38712 Federal Register / Vol. 80, No. 129 / Tuesday, July 7, 2015 / Notices

VII. Agency Contacts confidential trade secrets or commercial Date: July 17, 2015.
property such as patentable material, Time: 10:00 a.m. to 8:00 p.m.
1. Questions on the programmatic issues
and personal information concerning Agenda: To review and evaluate grant
may be directed to: Mr. Chris applications.
Buchanan, Director, ODSCT, 801 individuals associated with the grant
applications, the disclosure of which Place: National Institutes of Health, 6701
Thompson Avenue, Suite 220, Rockledge Drive, Bethesda, MD 20892.
Rockville, MD 20852, Telephone: would constitute a clearly unwarranted
Contact Person: Heidi B Friedman, Ph.D.,
(301) 443–1104, E-Mail: invasion of personal privacy.
Scientific Review Officer, Center for
Chris.Buchanan@ihs.gov. Name of Committee: National Institute on Scientific Review, National Institutes of
2. Questions on grants management and Drug Abuse Special Emphasis Panel; Seek, Health, 6701 Rockledge Drive, Room 1012A,
fiscal matters may be directed to: Test, Treat and Retain For Youth and Young MSC 7770, Bethesda, MD 20892, 301–379–
Mr. John Hoffman, Grants Adults Living with or at High Risk for 5632, hfriedman@csr.nih.gov.
Management Specialist, Division of Acquiring HIV (R01). This notice is being published less than 15
Date: July 9, 2015.
Grants Management, 801 Thompson days prior to the meeting due to the timing
Time: 8:00 a.m. to 4:00 p.m.
Avenue, TMP Suite 360, Rockville, Agenda: To review and evaluate grant
limitations imposed by the review and
MD 20852, Telephone: (301) 443– funding cycle.
applications.
5204, Fax: (301) 443–9602, E-Mail: Place: Churchill Hotel, 1914 Connecticut Name of Committee: Center for Scientific
John.Hoffman@ihs.gov. Avenue NW., Washington, DC 20009. Review Special Emphasis Panel Program
3. Questions on systems matters may be Contact Person: Nadine Rogers, Ph.D., Project: Computation and Experiment to
directed to: Mr. Paul Gettys, Grant Scientific Review Officer, Office of Determine Disordered Protein Ensembles.
Systems Coordinator, Division of Extramural Affairs, National Institute on Date: July 27–28, 2015.
Grants Management, 801 Thompson Drug Abuse, NIH, DHHS, 6001 Executive Time: 10:00 a.m. to 5:00 p.m.
Avenue, TMP Suite 360, Rockville, Blvd., Room 4229, MSC 9550, Bethesda, MD Agenda: To review and evaluate grant
20892–9550, 301–402–2105, rogersn2@ applications.
MD 20852, Phone: (301) 443–2114;
nida.nih.gov. Place: National Institutes of Health, 6701
or the DGM main line (301) 443– This notice is being published less than 15
5204, Fax: 301–443–9602, E-Mail: Rockledge Drive, Bethesda, MD 20892;
days prior to the meeting due to the timing (Virtual Meeting).
Paul.Gettys@ihs.gov. limitations imposed by the review and Contact Person: William A. Greenberg,
funding cycle.
VIII. Other Information Ph.D., Scientific Review Officer, Center for
(Catalogue of Federal Domestic Assistance Scientific Review, National Institutes of
The Public Health Service strongly Program Nos.: 93.279, Drug Abuse and Health, 6701 Rockledge Drive, Room 4168,
encourages all cooperative agreement Addiction Research Programs, National MSC 7806, Bethesda, MD 20892, (301) 435–
and contract recipients to provide a Institutes of Health, HHS) 1726, greenbergwa@csr.nih.gov.
smoke-free workplace and promote the Dated: June 30, 2015. Name of Committee: Center for Scientific
non-use of all tobacco products. In
Michelle Trout, Review Special Emphasis Panel; Myalgic
addition, Public Law 103–227, the Pro- Encephalomyelitis/Chronic Fatigue
Program Analyst, Office of Federal Advisory
Children Act of 1994, prohibits smoking Syndrome.
Committee Policy.
in certain facilities (or in some cases, Date: July 27–28, 2015.
[FR Doc. 2015–16527 Filed 7–6–15; 8:45 am]
any portion of the facility) in which Time: 10:00 a.m. to 4:00 p.m.
BILLING CODE 4140–01–P
regular or routine education, library, Agenda: To review and evaluate grant
day care, health care, or early childhood applications.
development services are provided to Place: National Institutes of Health, 6701
DEPARTMENT OF HEALTH AND
children. This is consistent with the Rockledge Drive, Bethesda, MD 20892
HUMAN SERVICES
HHS mission to protect and advance the (Virtual Meeting).
physical and mental health of the National Institutes of Health Contact Person: Lynn E. Luethke, Ph.D.,
American people. Scientific Review Officer, Center for
Center for Scientific Review Notice of Scientific Review, National Institutes of
Dated: June 29, 2015.
Closed Meetings Health, 6701 Rockledge Drive, Room 5166,
Robert G. McSwain, MSC 7844, Bethesda, MD 20892, (301) 806–
Acting Director, Indian Health Service. Pursuant to section 10(d) of the 3323,luethkel@csr.nih.gov.
[FR Doc. 2015–16620 Filed 7–6–15; 8:45 am] Federal Advisory Committee Act, as Name of Committee: Center for Scientific
BILLING CODE 4160–16–P amended (5 U.S.C. App.), notice is Review Special Emphasis Panel; Member
hereby given of the following meetings. Conflict: Language and Communication.
The meetings will be closed to the Date: August 7, 2015.
DEPARTMENT OF HEALTH AND public in accordance with the Time: 1:00 p.m. to 3:00 p.m.
HUMAN SERVICES provisions set forth in sections Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
National Institutes of Health as amended. The grant applications and Place: National Institutes of Health, 6701
the discussions could disclose Rockledge Drive, Bethesda, MD 20892,
National Institute on Drug Abuse; (Telephone Conference Call).
confidential trade secrets or commercial
Notice of Closed Meeting Contact Person: Biao Tian, Ph.D., Scientific
property such as patentable material, Review Officer, Center for Scientific Review,
Pursuant to section 10(d) of the and personal information concerning National Institutes of Health, 6701 Rockledge
Federal Advisory Committee Act, as individuals associated with the grant Drive, Room 3089B, MSC 7848, Bethesda,
amended (5 U.S.C. App), notice is applications, the disclosure of which MD 20892, (301) 402–4411,
tkelley on DSK3SPTVN1PROD with NOTICES

hereby given of the following meeting. would constitute a clearly unwarranted tianbi@csr.nih.gov.
The meeting will be closed to the invasion of personal privacy. (Catalogue of Federal Domestic Assistance
public in accordance with the Name of Committee: Center for Scientific Program Nos. 93.306, Comparative Medicine;
provisions set forth in sections Review Special Emphasis Panel RFA–DA15– 93.333, Clinical Research, 93.306, 93.333,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 015: Adolescent Brain Cognitive 93.337, 93.393–93.396, 93.837–93.844,
as amended. The grant applications and Development (ABCD) Study—Research 93.846–93.878, 93.892, 93.893, National
the discussions could disclose Project Sites (U01). Institutes of Health, HHS)

VerDate Sep<11>2014 20:31 Jul 06, 2015 Jkt 235001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\07JYN1.SGM 07JYN1

Document Created: 2015-12-15 13:27:17
Document Modified: 2015-12-15 13:27:17

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 9, 2015.
FR Citation		80 FR 38712

80 FR 38712 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 129 (July 7, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health